Manufacturer record

Gracure Pharmaceuticals Ltd. Brahman Bell Road: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Gracure Pharmaceuticals Ltd. Brahman Bell Road (Himachal Pradesh) was declared Not of Standard Quality in March 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: NT-190221, Pheniramine Maleate Tablets I.P. (MOREVIL-25 Tablets) (exp Jan 2021). RDTL Guwahati (state lab) found it not of standard quality: Physical Parameter. Listed in the March 2020 alert.

Records by type

1 record linked to Gracure Pharmaceuticals Ltd. Brahman Bell Road in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2020 to Mar 2020

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2020
1
Products affected
Other
Most common failure
Mar 2020
Latest alert

Flagged batches per year

2020 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pheniramine Maleate Tablets I.P. (MOREVIL-25 Tablets) Batch NT-190221Mfg Feb 2019 · Exp Jan 2021 Physical ParameterOther RDTL GuwahatiState lab Mar 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.